1. DcR3-associated risk score: correlating better prognosis and enhanced predictive power in colorectal cancer
   Ying Duan et al, 2024, Discover Oncology CrossRef
2. Shining LIGHT on the metabolic role of the cytokine TNFSF14 and the implications on hepatic IL‐6 production
   Bernadette M Saunders et al, 2018, Immunology & Cell Biology CrossRef
3. DcR3 combined with hematological traits serves as a valuable biomarker for the diagnosis of cancer metastasis
   Junxin Li et al, 2017, Oncotarget CrossRef
4. TNFSF14-Derived Molecules as a Novel Treatment for Obesity and Type 2 Diabetes
   Mark Agostino et al, 2021, International Journal of Molecular Sciences CrossRef
5. The role of sTNFSF14 in the liver mitochondrial dynamics in obese patients
   A. A. Komar et al, 2021, Bulletin of Siberian Medicine CrossRef
6. A stable, engineered TL1A ligand co-stimulates T cells via specific binding to DR3
   Adam Zwolak et al, 2022, Scientific Reports CrossRef
7. Mechanisms of Apoptosis Resistance to NK Cell-Mediated Cytotoxicity in Cancer
   Christian Sordo-Bahamonde et al, 2020, International Journal of Molecular Sciences CrossRef
8. Construction and Validation of a Novel Immune Checkpoint-Related Model in Clear Cell Renal Cell Carcinoma
   ZhiXiang Fan et al, 2022, Disease Markers CrossRef
9. Prognostic value of DcR3 in solid tumors: A meta-analysis
   Hua Ge et al, 2018, Clinica Chimica Acta CrossRef
10. Research Progress of DcR3 in the Diagnosis and Treatment of Sepsis
    Jingqian Su et al, 2023, International Journal of Molecular Sciences CrossRef
11. Anti‐oral cancer effects of triptolide by downregulation of DcR3 in vitro, in vivo, and in preclinical patient‐derived tumor xenograft model
    Cheng‐Yu Yang et al, 2019, Head & Neck CrossRef
12. TNFSF14: LIGHTing the Way for Effective Cancer Immunotherapy
    Joseph G. Skeate et al, 2020, Frontiers in Immunology CrossRef